Conquering Diseases

Study Of An Investigational Drug In Combination With Systemic Corticosteroids Non-Ambulatory Dmd


Seeking young men aged 12 and older living with Duchenne Muscular Dystrophy (DMD) who are not able to walk and have been on a stable dose of corticosteroids for at least 6 months for a study of an investigational drug.


We are studying the comparing whether adding an investigational drug is better than a placebo (looks like the drug but has no medicine) in maintianing when added to systemic corticosteroid treatment

What we're hoping for

evaluate the efficacy and safety of pamrevlumab versus placebo in combination with systemic corticosteroids in subjects with Duchenne muscular dystrophy (non-ambulatory, age 12 years and older).

Additional Information Identifier: NCT04371666

 Principal Investigator

Brenda  Wong, MD

UMass Memorial Health Care

 Study Contact

Sarah  Figueira



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655